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Two recent studies published in Nature (Baek et al. 2008; Selbach et al., 2008) analyze changes in 
the proteome in response to individual microRNAs (miRNAs). This approach is a powerful means 
to identify miRNA targets and to quantify the contribution of translational repression to post-
transcriptional gene silencing by miRNAs.MicroRNAs (miRNAs) are small noncod-
ing RNAs, approximately 22 nucleotides 
in length, that repress target mRNAs 
through an antisense mechanism. In ani-
mals, miRNAs typically target sequences 
in the transcript 3′ untranslated regions 
that are only partially complementary to 
the miRNA, causing less protein to be 
made. The mechanisms by 
which this occurs are less 
clear. Many target mRNAs 
undergo degradation, likely 
initiated by removal of the 
poly(A) tail. Other, stable target 
mRNAs might be repressed 
at the initiation or elongation 
stage of translation (Filipow-
icz et al., 2008). The fact that 
miRNAs can cause degrada-
tion of their targets has been 
widely exploited to identify 
such targets through microar-
ray analysis. However, targets 
that are not susceptible to 
degradation would be missed. 
Enter the Bartel and Rajewsky 
labs, which have now estab-
lished in spectacular tours de 
force proteomics approaches 
to detect and quantify miRNA-
induced changes in protein 
accumulation (Baek et al., 
2008; Selbach et al., 2008).
Both approaches depend 
on the high levels of accuracy 
and sensitivity with which mass 
spectrometry can identify and 
quantify proteins from com-
plex mixtures. With a method 
known as SILAC (stable-iso-
tope labeling by amino acids in 
cultured cells), it is possible to label pro-
teins during translation through incorpora-
tion of “heavy” amino acids. Proteomes 
from cells grown in the presence of dif-
ferent labels, exposed to different experi-
mental manipulations, can be compared 
side by side with the analyzed peptides 
showing up as distinct peaks in the mass 
spectrometer (Figure 1). Rajewsky and 
coworkers used a particularly ingenious 
implementation of SILAC termed pulsed 
SILAC (pSILAC) (Selbach et al., 2008). 
In this approach, labeling is restricted to 
newly synthesized proteins, permitting the 
determination of protein synthesis rates 
and providing high sensitivity. In contrast, 
conventional SILAC quantifies 
changes in protein concentra-
tions, which respond to addi-
tional factors including intrinsic 
protein half-lives and regulated 
turnover. However, assuming 
that the total concentration of 
a protein rather than its cur-
rent rate of synthesis deter-
mines biological outcomes, 
changes identified by SILAC 
might be equally relevant, such 
that SILAC and pSILAC should 
be viewed as complementary 
approaches.
Both groups initially 
focused on human HeLa 
cells, which they transfected 
with individual mature miR-
NAs. Whereas the Bartel 
group examined the effects 
on nuclear proteins, Rajewsky 
and colleagues looked at total 
protein composition. Examin-
ing 2000 to 5000 distinct pro-
teins each, both approaches 
were able to expand on an 
earlier effort (Vinther et al., 
2006), although are still some 
way from a full proteome. 
Consistent with microarray 
data, widespread changes 
in gene expression were 
Figure 1. Comparison of SILAC and pSILAC
SILAC (stable-isotope labeling by amino acids in cultured cells) is a method 
for labeling proteins during translation through incorporation of “heavy” amino 
acids. In pulsed SILAC (pSILAC), cells are experimentally manipulated while 
growing in “light” (L) SILAC medium. Subsequently, treated and control cells 
are transferred to distinctly labeled SILAC media. After one or a few doublings, 
cells are harvested and combined before protein is extracted. Protein present 
before treatment will show up as an L peak in the mass spectrograph and can 
be ignored. The effect of the treatment on protein production rates can be 
calculated as the ratio of signal at the “medium-heavy” (M) and “heavy” (H) 
peaks. In regular SILAC, cells are pregrown for several doublings in M or H 
medium (or, more typically, L or H medium) before being exposed to experi-
mental treatment. There will thus only be two peaks of protein, each reflecting 
a mixture of newly synthesized protein and preexisting stable protein.560 Cell 134, August 22, 2008 ©2008 Elsevier Inc.
observed, with hundreds of proteins 
changing detectably in a typical experi-
ment, many of them quite significantly.
Analysis of changes in mRNA levels 
indicated that repression of protein is 
frequently mirrored by decreased tran-
script levels (Selbach et al., 2008; Baek 
et al., 2008), suggesting that most tar-
gets can be identified without a need for 
sophisticated proteomics approaches. 
However, pSILAC in particular identified 
a substantial number of targets where 
translational repression is the major com-
ponent of mRNA silencing (Selbach et al., 
2008). One particularly intriguing example 
involves the miRNA-processing enzyme 
Dicer, whose mRNA levels change by 
30% when the miRNA let-7b is blocked, 
whereas its translation rate changes more 
than 4-fold. On the basis of the moderate 
change in Dicer mRNA levels, few people 
might have been inclined to investigate 
Dicer as a let-7b target.
The finding that mRNA degradation and 
protein repression typically occur together 
brings up the possibility that mRNA deg-
radation is a major determinant of miRNA 
repression. There are two caveats to this 
interpretation. First, both groups used 
microarray profiling strategies that depend 
on labeling of polyadenylated mRNA to 
assess mRNA levels. Because deadeny-
lation can affect not only mRNA stability 
but also translation, this approach might 
underestimate the contribution of transla-
tional repression. Second, it remains pos-
sible that translational repression might 
precede degradation. Consistent with 
this notion, mRNA levels were found to 
decrease with prolonged miRNA exposure 
(Selbach et al., 2008). Moreover, whereas 
target degradation appeared to correlate 
well with changes in protein concentra-
tions (Baek et al., 2008), miRNAs had 
much more pronounced effects on rates 
of protein synthesis measured by pSILAC 
(Selbach et al., 2008). It will be informative 
to learn more about the targets that are 
regulated preferentially at the translational 
level and to understand their relevance to 
the cellular function of miRNAs. Do these 
targets need to be regulated within partic-
ularly tight boundaries? Can their repres-
sion be reversed? What is causing their 
stability: is there a difference in the archi-
tecture of their target sites, or are there 
other factors in the cells that prevent their 
degradation?Ectopic expression or overexpression 
of miRNAs might not produce the same 
effects as endogenous miRNAs. Both 
groups performed additional experi-
ments to address this possibility. The 
Rajewsky group examined the effect 
of blocking an abundant endogenous 
miRNA, let-7b, in HeLa cells and found 
that many of the genes that had been 
downregulated when overexpressing 
let-7b were now upregulated (Selbach 
et al., 2008). Although overexpression of 
let-7 would thus appear to affect expres-
sion of many of the same genes that are 
affected when blocking this miRNA, the 
extent of deregulation upon let-7 overex-
pression was higher than that seen with 
inhibition of let-7.
The Bartel group circumvented the 
problem of transfection, and the associ-
ated cellular stress, by examining nuclear 
and cytoplasmic proteins from mutant 
mouse neutrophils lacking expression 
of miR-223 and also found that changes 
in protein expression were compara-
ble to the patterns seen in transfection 
experiments (Baek et al., 2008). This 
experiment is important for another 
reason: in the overexpression experi-
ments, most miRNAs were transfected 
into the cells as perfectly complemen-
tary, double-stranded miRNA mimics. In 
flies and worms, miRNAs derived from 
such perfectly complementary precur-
sors are sorted into different effector 
complexes than are the miRNAs derived 
from the typical miRNA precursors con-
taining loops and bulges (Bellare and 
Sontheimer, 2007). Although it is not 
clear that similar mechanisms operate in 
humans, the mode of exogenous miRNA 
provision might affect the mechanism of 
action used by miRNAs to silence their 
targets.
With one miRNA causing expres-
sion changes in hundreds of proteins, 
it remains an open question how many 
of these changes are important to the 
function of the individual miRNA. Many 
of these effects might be neutral, with 
altered levels not compromising the 
cellular function of the affected pro-
tein. For the others, it will be interesting 
to learn whether the proteins that are 
more strongly regulated have greater 
relevance to miRNA function, consis-
tent with a switch-like model of miRNA 
activity, or whether fine-tuning, possi-Cell 13bly affecting many targets by a modest 
extent, is more frequently the important 
scenario (Hobert, 2007). However, when 
interpreting the extent to which protein 
expression changes, it is worthwhile to 
keep in mind that miRNA activity itself 
can be regulated. Effects seen in one cell 
line might be quite different from those 
found in another in which other potential 
target genes and also other modulators 
of miRNA activity may be expressed 
(Mishima et al., 2006; Kedde et al., 2007; 
Bhattacharyya et al., 2006). It will thus 
be particularly illuminating to study the 
effects of the same miRNA in different 
cells.
In this context, it is somewhat disap-
pointing that neither report comments 
on the fraction and identity of previously 
validated targets that have been recov-
ered with the new approaches—despite 
the fact that there is an abundance of 
such targets, certainly for miR-1 and 
let-7. This would be particularly relevant 
for miR-1—whose effect on HeLa cells 
was examined in both the new (Baek et 
al., 2008; Selbach et al., 2008) and the 
earlier reports (Vinther et al., 2006)—so 
that comparison of the results could pro-
vide some idea of the robustness of the 
methods. Ultimately, it would be most 
interesting to perform comparable SILAC 
experiments in additional systems, par-
ticularly in whole animals (Krüger et al., 
2008).
Beyond information on specific tar-
gets, identification of this large cohort 
of genes regulated by miRNAs might tell 
us more about sequence features that 
define miRNA targets and thus improve 
computational target prediction. On 
this issue, conclusions diverge. With 
pSILAC, the best algorithms reach a 
false-positive rate below 40% (Selbach 
et al., 2008). It is here that the capa-
bility of pSILAC to look at translation 
rates, subject to fewer indirect effects 
than are protein concentrations, might 
reap its greatest rewards. In contrast, 
when SILAC was used, even the most 
successful algorithms still had a false-
positive rate greater than two out of 
three (Baek et al., 2008). Conversely, a 
substantial fraction of proteins that did 
change were not predicted as targets. 
Thus, both papers provide evidence 
that target predictions developed 
from microarray analyses largely apply 4, August 22, 2008 ©2008 Elsevier Inc. 561
to targets regulated by translational 
repression, but additional improve-
ments are needed, possibly resulting 
in the identification of new sequence 
and structure parameters for this tar-
get class.
The two reports (Baek et al., 2008; Sel-
bach et al., 2008) have provided a wealth 
of data that will keep both experimental 
and computational biologists busy for 
some time to come. The wider applica-
tion of these powerful new approaches 
to different experimental systems will 
help to address many of the questions 
that we have raised here.562 Cell 134, August 22, 2008 ©2008 Elsev
Mammals have developed elaborate 
mechanisms to prevent disease and injury 
and to initiate healing responses should 
those prevention mechanisms fail. A good 
example of a disease-prevention mecha-
nism is cellular senescence, a state in 
which cell division is permanently arrested 
(reviewed in Collado et al., 2007). This 
phenomenon was originally discovered in 
cultured primary cells that stop proliferat-
ing after a finite number of divisions (rep-
licative senescence). We now know that 
replicative senescence is due, at least in 
part, to erosion of telomeres, which occurs 
at each cell division. Senescent cells 
have a distinct phenotype that includes 
characteristic alterations in morphology, 
gene expression patterns, and chromatin 
structure. Specific genes are known to be 
required for senescence induction, thus 
revealing the existence of a defined genetic 
program. But why would cells develop a 
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mechanism to permanently halt prolifera-
tion? Findings in experimental mouse can-
cer models and with human tumor sam-
ples hinted at the answer: precancerous 
tissues are composed of senescent cells 
(reviewed in Campisi, 2005; Sharpless 
and DePinho, 2005). These observations 
led to the notion that induction of cellular 
senescence provides an intrinsic barrier 
to cancer development by preventing the 
proliferation of cells that are damaged or 
at risk for neoplastic transformation. In this 
issue, Krizhanovsky et al. (2008) add a new 
dimension to the cellular senescence story 
by demonstrating that senescence is also 
required in the normal response to injury 
in the liver.
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mouse model, Krizhanovsky and col-
leagues, rather surprisingly, observed 
senescent cells in the liver. In their liver 
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Res. 34, e107.injury model, mice are treated with the 
chemical carbon tetrachloride to induce 
fibrosis, the primary response of the 
liver to injury. Fibrosis is a wound heal-
ing process characterized by the depo-
sition of extracellular matrix components 
including collagens, proteoglycans, and 
fibronectins, which help to encapsulate 
the injury site (reviewed in Friedman, 
2008). Liver fibrosis is a precursor to 
cirrhosis, a significant health problem 
caused by diverse liver-damaging agents 
such as excessive alcohol, viral hepatitis, 
and toxins. Hepatic stellate cells (HSCs) 
are the primary modulators of liver fibro-
sis and are activated following damage 
to hepatocytes, the predominant cell 
type in liver tissue. Activated HSCs are 
characterized by increased prolifera-
tion and motility and, most importantly, 
by increased synthesis of extracellular 
matrix components. Krizhanovsky et al. 
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